EcoDrugPlus

Ensembl ID : ENSNBRG00000015166
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSNBRG00000000683
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSNBRG00000020408
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSNBRG00000010693
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSNBRG00000020655
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSNBRG00000015053
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSNBRG00000001994
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSNBRG00000022169
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSNBRG00000002032
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSNBRG00000007482
Gene Symbol: -
Cross references: -
167 Possible Orthologues:

Ensembl ID : ENSNBRG00000007313
Gene Symbol: -
Cross references: -
139 Possible Orthologues:

Ensembl ID : ENSNBRG00000001992
Gene Symbol: -
Cross references: -
167 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).